PAREXEL® Access eHub:

Value Through Evidence

Back to Content Hub

Late phase partnerships

As they say: ‘two heads are better than one’ and taking an integrated approach to late phase partnerships can unlock the value of your product for stakeholders. Maximize drug potential through strategy, evidence and clear communication.

Partnering with an experienced CRO is particularly beneficial in late phase clinical research as commercialization and reimbursement data requirements will have been considered from the offset. By outsourcing strategy, clinical trials benefit from a range of expert minds and a committed study partner that will spearhead market access. 

An integrated approach helps: 

• Identify data needed 

• Access realization 

• Data generation 

• Communications strategy 

• Communications execution 

Infographic: Late Phase Partnerships

Share this: